Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NKGen Biotech, Inc. | Interim CFO | Common Stock | 2.44M | $8.02M | $3.29 | Dec 1, 2023 | By Graf Acquisition Partners IV LLC |
NKGen Biotech, Inc. | Interim CFO | Common Stock | 693 | $2.28K | $3.29 | Dec 4, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NKGN | NKGen Biotech, Inc. | Dec 1, 2023 | 2 | $2.17K | 4 | Dec 5, 2023 | Interim CFO |
NKGN | NKGen Biotech, Inc. | Nov 20, 2023 | 2 | $67.30 | 4 | Nov 22, 2023 | Interim CFO |
GFOR | Graf Acquisition Corp. IV | May 28, 2021 | 2 | $49.5K | 4 | Jun 3, 2021 | Chief Executive Officer |
GFOR | Graf Acquisition Corp. IV | May 25, 2021 | 3 | $4.96K | 4 | May 27, 2021 | Chief Executive Officer |
GFOR | Graf Acquisition Corp. IV | May 21, 2021 | 3 | $12.9K | 4 | May 25, 2021 | Chief Executive Officer |